Condition
Bioequivalence trial in healthy volunteers
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Phase 1 (2)
Trial Status
Unknown1
Not Yet Recruiting1
Clinical Trials (2)
Showing 2 of 2 trials
SYF502a3ef2e59e41fcbb9f901bf4239a72Phase 1Unknown
Bioequivalence of two transdermal therapeutic systems delivering 100 mcg/h fentanyl
SYF96cad395573c4730823070e66f79192dPhase 1Not Yet Recruiting
Bioequivalence of two transdermal therapeutic systems delivering 100 mcg/h fentanyl
Showing all 2 trials
Research Network
Active Sponsors
- Lavipharm S.A.2
- CCDRD Cooperative Clinical Drug Research and Development AG2